The sacral nerve stimulation devices market size has grown rapidly in recent years. It will grow from $1.48 billion in 2025 to $1.65 billion in 2026 at a compound annual growth rate (CAGR) of 11.5%. The growth in the historic period can be attributed to growing prevalence of urinary incontinence, increasing geriatric population, advancements in neuromodulation technology, wider clinical acceptance of nerve stimulation therapies, expansion of urology specialty services.
The sacral nerve stimulation devices market size is expected to see rapid growth in the next few years. It will grow to $2.54 billion in 2030 at a compound annual growth rate (CAGR) of 11.4%. The growth in the forecast period can be attributed to increasing adoption of smart implantable devices, rising demand for long-term continence management, expansion of outpatient neuromodulation procedures, growing focus on personalized neurological therapies, increasing investments in bioelectronic medicine. Major trends in the forecast period include increasing adoption of implantable neuromodulation devices, rising demand for minimally invasive bladder control treatments, growing integration of programmable stimulation technologies, expansion of long-term neurological therapy solutions, enhanced focus on patient-specific therapy customization.
The growing prevalence of urological disorders is expected to boost the sacral nerve stimulation devices market. Urological disorders include various conditions affecting the urinary tract, kidneys, bladder, and prostate, ranging from acute to chronic. These disorders can be caused by multiple factors, including lifestyle issues such as poor diet, dehydration, and lack of exercise, which can contribute to kidney stones and other painful urinary tract conditions. Sacral nerve stimulation devices offer a minimally invasive treatment option for managing conditions such as urinary and fecal incontinence. For example, in April 2024, the National Institute of Diabetes and Digestive and Kidney Diseases reported that, on average, 651,446 individuals aged 65 and older are newly diagnosed with urinary incontinence annually. This growing prevalence of urological disorders is anticipated to drive the demand for sacral nerve stimulation devices.
Major companies in the Sacral Nerve Stimulation (SNS) devices market are focusing on developing advanced solutions, such as recharge-free sacral neuromodulation systems, to improve patient convenience and therapy adherence. Recharge-free sacral neuromodulation systems are implantable devices that stimulate the sacral nerves to treat bladder and bowel dysfunction without requiring regular battery recharging. For instance, in January 2025, Medtronic PLC, an Ireland-based medical technology company, received FDA approval in India for the InterStim X Sacral Neuromodulation (SNM) system to treat conditions such as overactive bladder (OAB), chronic fecal incontinence (FI), and non-obstructive urinary retention. The system features a proprietary fifth-generation battery delivering over 10 years of therapy without recharging, extendable up to 15 years on low-energy settings. It includes a smart programmer, similar to a smartphone, allowing patients to adjust up to 11 therapy settings discreetly at home or on the go. Additionally, it supports SureScan MRI technology, enabling safe full-body 1.5T and 3T MRI scans, with MRI mode controlled by patients under physician guidance.
In January 2024, Boston Scientific Corporation, a US-based biotechnology firm, acquired Axonics for $3.7 billion. This acquisition aims to expand Boston Scientific's medical technology portfolio by integrating Axonics' specialized devices for treating urinary and bowel dysfunction. Axonics Inc., based in the U.S., is known for its implantable sacral neuromodulation (SNM) systems designed to address urinary urge incontinence and urinary urgency frequency (UUF).
Major companies operating in the sacral nerve stimulation devices market are Abbott, Medtronic plc, Boston Scientific Corporation, Axonics Modulation Technologies, Laborie Medical Technologies, Beijing PINS Medical Co. Ltd., Neuspera Medical, Coloplast Group, Medtronic Neurovascular, NeuroPace Inc., Aleva Neurotherapeutics, LivaNova Neuromodulation, Nalu Medical, SetPoint Medical, NeuroSigma Inc., Saluda Medical, Soterix Medical, Inspire Medical Systems Inc., Synapse Biomedical Inc., Bioinduction Ltd.
North America was the largest region in the sacral nerve stimulation devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the sacral nerve stimulation devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the sacral nerve stimulation devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the sacral nerve stimulation devices market by increasing costs of imported implantable electrodes, pulse generators, microelectronics, batteries, and programming units. Healthcare providers in North America and Europe are most affected due to reliance on specialized imported components, while Asia-Pacific faces cost pressure on device manufacturing and exports. These tariffs are increasing procedural costs and limiting access in some markets. However, they are also driving domestic production, regional component sourcing, and innovation in compact and cost-efficient neuromodulation systems.
The sacral nerve stimulation devices market research report is one of a series of new reports that provides sacral nerve stimulation devices market statistics, including sacral nerve stimulation devices industry global market size, regional shares, competitors with a sacral nerve stimulation devices market share, detailed sacral nerve stimulation devices market segments, market trends and opportunities, and any further data you may need to thrive in the sacral nerve stimulation devices industry. This sacral nerve stimulation devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
A sacral nerve stimulation device is a medical implant that uses electrical impulses to modulate nerves in the sacral area. It is used to treat conditions such as urinary incontinence and overactive bladder by regulating nerve activity, aiming to improve bladder function and enhance the quality of life for patients through targeted neurological intervention.
The main types of sacral nerve stimulation devices include electrical muscle stimulation devices and transcutaneous electrical nerve stimulation (TENS) devices. An electrical muscle stimulation device delivers electrical impulses to muscles via electrodes placed on the skin. Products in this category include external sacral nerve stimulation devices and implantable sacral nerve stimulation devices, which cater to different age groups such as pediatrics, adults, and geriatrics. These devices are used for various applications, including urinary incontinence, fecal incontinence, and other conditions, and are provided through hospitals, ambulatory surgical centers, and specialty clinics.
The sacral nerve stimulation devices market consists of sales of pulse generators, insulated wires, and electrode arrays. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The sacral nerve stimulation devices market size is expected to see rapid growth in the next few years. It will grow to $2.54 billion in 2030 at a compound annual growth rate (CAGR) of 11.4%. The growth in the forecast period can be attributed to increasing adoption of smart implantable devices, rising demand for long-term continence management, expansion of outpatient neuromodulation procedures, growing focus on personalized neurological therapies, increasing investments in bioelectronic medicine. Major trends in the forecast period include increasing adoption of implantable neuromodulation devices, rising demand for minimally invasive bladder control treatments, growing integration of programmable stimulation technologies, expansion of long-term neurological therapy solutions, enhanced focus on patient-specific therapy customization.
The growing prevalence of urological disorders is expected to boost the sacral nerve stimulation devices market. Urological disorders include various conditions affecting the urinary tract, kidneys, bladder, and prostate, ranging from acute to chronic. These disorders can be caused by multiple factors, including lifestyle issues such as poor diet, dehydration, and lack of exercise, which can contribute to kidney stones and other painful urinary tract conditions. Sacral nerve stimulation devices offer a minimally invasive treatment option for managing conditions such as urinary and fecal incontinence. For example, in April 2024, the National Institute of Diabetes and Digestive and Kidney Diseases reported that, on average, 651,446 individuals aged 65 and older are newly diagnosed with urinary incontinence annually. This growing prevalence of urological disorders is anticipated to drive the demand for sacral nerve stimulation devices.
Major companies in the Sacral Nerve Stimulation (SNS) devices market are focusing on developing advanced solutions, such as recharge-free sacral neuromodulation systems, to improve patient convenience and therapy adherence. Recharge-free sacral neuromodulation systems are implantable devices that stimulate the sacral nerves to treat bladder and bowel dysfunction without requiring regular battery recharging. For instance, in January 2025, Medtronic PLC, an Ireland-based medical technology company, received FDA approval in India for the InterStim X Sacral Neuromodulation (SNM) system to treat conditions such as overactive bladder (OAB), chronic fecal incontinence (FI), and non-obstructive urinary retention. The system features a proprietary fifth-generation battery delivering over 10 years of therapy without recharging, extendable up to 15 years on low-energy settings. It includes a smart programmer, similar to a smartphone, allowing patients to adjust up to 11 therapy settings discreetly at home or on the go. Additionally, it supports SureScan MRI technology, enabling safe full-body 1.5T and 3T MRI scans, with MRI mode controlled by patients under physician guidance.
In January 2024, Boston Scientific Corporation, a US-based biotechnology firm, acquired Axonics for $3.7 billion. This acquisition aims to expand Boston Scientific's medical technology portfolio by integrating Axonics' specialized devices for treating urinary and bowel dysfunction. Axonics Inc., based in the U.S., is known for its implantable sacral neuromodulation (SNM) systems designed to address urinary urge incontinence and urinary urgency frequency (UUF).
Major companies operating in the sacral nerve stimulation devices market are Abbott, Medtronic plc, Boston Scientific Corporation, Axonics Modulation Technologies, Laborie Medical Technologies, Beijing PINS Medical Co. Ltd., Neuspera Medical, Coloplast Group, Medtronic Neurovascular, NeuroPace Inc., Aleva Neurotherapeutics, LivaNova Neuromodulation, Nalu Medical, SetPoint Medical, NeuroSigma Inc., Saluda Medical, Soterix Medical, Inspire Medical Systems Inc., Synapse Biomedical Inc., Bioinduction Ltd.
North America was the largest region in the sacral nerve stimulation devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the sacral nerve stimulation devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the sacral nerve stimulation devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the sacral nerve stimulation devices market by increasing costs of imported implantable electrodes, pulse generators, microelectronics, batteries, and programming units. Healthcare providers in North America and Europe are most affected due to reliance on specialized imported components, while Asia-Pacific faces cost pressure on device manufacturing and exports. These tariffs are increasing procedural costs and limiting access in some markets. However, they are also driving domestic production, regional component sourcing, and innovation in compact and cost-efficient neuromodulation systems.
The sacral nerve stimulation devices market research report is one of a series of new reports that provides sacral nerve stimulation devices market statistics, including sacral nerve stimulation devices industry global market size, regional shares, competitors with a sacral nerve stimulation devices market share, detailed sacral nerve stimulation devices market segments, market trends and opportunities, and any further data you may need to thrive in the sacral nerve stimulation devices industry. This sacral nerve stimulation devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
A sacral nerve stimulation device is a medical implant that uses electrical impulses to modulate nerves in the sacral area. It is used to treat conditions such as urinary incontinence and overactive bladder by regulating nerve activity, aiming to improve bladder function and enhance the quality of life for patients through targeted neurological intervention.
The main types of sacral nerve stimulation devices include electrical muscle stimulation devices and transcutaneous electrical nerve stimulation (TENS) devices. An electrical muscle stimulation device delivers electrical impulses to muscles via electrodes placed on the skin. Products in this category include external sacral nerve stimulation devices and implantable sacral nerve stimulation devices, which cater to different age groups such as pediatrics, adults, and geriatrics. These devices are used for various applications, including urinary incontinence, fecal incontinence, and other conditions, and are provided through hospitals, ambulatory surgical centers, and specialty clinics.
The sacral nerve stimulation devices market consists of sales of pulse generators, insulated wires, and electrode arrays. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Sacral Nerve Stimulation Devices Market Characteristics
3. Sacral Nerve Stimulation Devices Market Supply Chain Analysis
4. Global Sacral Nerve Stimulation Devices Market Trends and Strategies
5. Sacral Nerve Stimulation Devices Market Analysis of End Use Industries
7. Global Sacral Nerve Stimulation Devices Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Sacral Nerve Stimulation Devices Total Addressable Market (TAM) Analysis for the Market
9. Sacral Nerve Stimulation Devices Market Segmentation
10. Sacral Nerve Stimulation Devices Market Regional and Country Analysis
11. Asia-Pacific Sacral Nerve Stimulation Devices Market
12. China Sacral Nerve Stimulation Devices Market
13. India Sacral Nerve Stimulation Devices Market
14. Japan Sacral Nerve Stimulation Devices Market
15. Australia Sacral Nerve Stimulation Devices Market
16. Indonesia Sacral Nerve Stimulation Devices Market
17. South Korea Sacral Nerve Stimulation Devices Market
18. Taiwan Sacral Nerve Stimulation Devices Market
19. South East Asia Sacral Nerve Stimulation Devices Market
20. Western Europe Sacral Nerve Stimulation Devices Market
21. UK Sacral Nerve Stimulation Devices Market
22. Germany Sacral Nerve Stimulation Devices Market
23. France Sacral Nerve Stimulation Devices Market
24. Italy Sacral Nerve Stimulation Devices Market
25. Spain Sacral Nerve Stimulation Devices Market
26. Eastern Europe Sacral Nerve Stimulation Devices Market
27. Russia Sacral Nerve Stimulation Devices Market
28. North America Sacral Nerve Stimulation Devices Market
29. USA Sacral Nerve Stimulation Devices Market
30. Canada Sacral Nerve Stimulation Devices Market
31. South America Sacral Nerve Stimulation Devices Market
32. Brazil Sacral Nerve Stimulation Devices Market
33. Middle East Sacral Nerve Stimulation Devices Market
34. Africa Sacral Nerve Stimulation Devices Market
36. Sacral Nerve Stimulation Devices Market Competitive Landscape and Company Profiles
37. Sacral Nerve Stimulation Devices Market Other Major and Innovative Companies
40. Sacral Nerve Stimulation Devices Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Sacral Nerve Stimulation Devices Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses sacral nerve stimulation devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for sacral nerve stimulation devices? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The sacral nerve stimulation devices market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Technology Modality: Implantable Sacral Neuromodulation; External Sacral Neuromodulation2) By Product: External Sacral Nerve Stimulation Devices; Implantable Sacral Nerve Stimulation Devices
3) By Age Group: Pediatrics; Adults; Geriatrics
4) By Application: Urinary Incontinence; Fecal Incontinence; Bowel Dysfunction; Other Applications
5) By End User: Hospitals; Ambulatory Surgical Centers; Specialty Clinics
Subsegments:
1) By Implantable Sacral Neuromodulation: Rechargeable Implantable SNS Systems; Non-Rechargeable Implantable SNS Systems2) By External Sacral Neuromodulation: Transcutaneous Sacral Neuromodulation Systems; Wearable External Neuromodulation Devices
Companies Mentioned: Abbott; Medtronic plc; Boston Scientific Corporation; Axonics Modulation Technologies; Laborie Medical Technologies; Beijing PINS Medical Co. Ltd.; Neuspera Medical; Coloplast Group; Medtronic Neurovascular; NeuroPace Inc.; Aleva Neurotherapeutics; LivaNova Neuromodulation; Nalu Medical; SetPoint Medical; NeuroSigma Inc.; Saluda Medical; Soterix Medical; Inspire Medical Systems Inc.; Synapse Biomedical Inc.; Bioinduction Ltd
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Sacral Nerve Stimulation Devices market report include:- Abbott
- Medtronic plc
- Boston Scientific Corporation
- Axonics Modulation Technologies
- Laborie Medical Technologies
- Beijing PINS Medical Co. Ltd.
- Neuspera Medical
- Coloplast Group
- Medtronic Neurovascular
- NeuroPace Inc.
- Aleva Neurotherapeutics
- LivaNova Neuromodulation
- Nalu Medical
- SetPoint Medical
- NeuroSigma Inc.
- Saluda Medical
- Soterix Medical
- Inspire Medical Systems Inc.
- Synapse Biomedical Inc.
- Bioinduction Ltd
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 1.65 Billion |
| Forecasted Market Value ( USD | $ 2.54 Billion |
| Compound Annual Growth Rate | 11.4% |
| Regions Covered | Global |
| No. of Companies Mentioned | 21 |
